share_log

Mangoceuticals | EFFECT: Others

Mangoceuticals | EFFECT: Others

Mangoceuticals | EFFECT：其他
美股sec公告 ·  05/10 06:09
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 registration statement of Mangoceuticals, Inc. effective as of May 9, 2024, at 4:30 PM. This announcement marks a significant milestone for Mangoceuticals, indicating that the company has met the necessary regulatory requirements to move forward with its plans as detailed in the Form S-1 filing. The effectiveness of the registration statement is a critical step for Mangoceuticals, potentially paving the way for a future public offering or other capital-raising activities as outlined in their filing with the SEC.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 registration statement of Mangoceuticals, Inc. effective as of May 9, 2024, at 4:30 PM. This announcement marks a significant milestone for Mangoceuticals, indicating that the company has met the necessary regulatory requirements to move forward with its plans as detailed in the Form S-1 filing. The effectiveness of the registration statement is a critical step for Mangoceuticals, potentially paving the way for a future public offering or other capital-raising activities as outlined in their filing with the SEC.
美国证券交易委员会（SEC）已宣布Mangoceuticals, Inc.的S-1表格注册声明自2024年5月9日下午4点30分起生效。该公告标志着Mangoceuticals的一个重要里程碑，表明该公司已满足必要的监管要求，以推进S-1表格文件中详述的计划。注册声明的有效性是Mangoceuticals的关键一步，它有可能为未来向美国证券交易委员会提交的文件中概述的公开募股或其他筹资活动铺平道路。
美国证券交易委员会（SEC）已宣布Mangoceuticals, Inc.的S-1表格注册声明自2024年5月9日下午4点30分起生效。该公告标志着Mangoceuticals的一个重要里程碑，表明该公司已满足必要的监管要求，以推进S-1表格文件中详述的计划。注册声明的有效性是Mangoceuticals的关键一步，它有可能为未来向美国证券交易委员会提交的文件中概述的公开募股或其他筹资活动铺平道路。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息